Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001231919-26-000186

Director acquired 6,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2026-02-19 Grant or award +6,200 6,200 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2026-02-19 Grant or award · Stock Option (Right to Buy) +8,300 8,300 I
Loading xslF345X05/form4-02212026_120253.xml…